tradingkey.logo

Labcorp Holdings Inc

LH
查看详细走势图
264.180USD
-0.640-0.24%
收盘 12/12, 16:00美东报价延迟15分钟
21.93B总市值
25.77市盈率 TTM

Labcorp Holdings Inc

264.180
-0.640-0.24%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.24%

5天

+2.24%

1月

-1.38%

6月

+1.17%

今年开始到现在

+15.20%

1年

+13.87%

查看详细走势图

TradingKey Labcorp Holdings Inc股票评分

单位: USD 更新时间: 2025-12-12

操作建议

Labcorp Holdings Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗服务供应商行业排名17/78位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价299.75。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Labcorp Holdings Inc评分

相关信息

行业排名
17 / 78
全市场排名
87 / 4592
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 21 位分析师
买入
评级
299.753
目标均价
+15.32%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Labcorp Holdings Inc亮点

亮点风险
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
高分红
公司属于高分红公司,最新股息支付率32.56%
估值低估
公司最新PE估值25.77,处于3年历史低位
机构加仓
最新机构持股83.09M股,环比增加0.91%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值94.00
活跃度降低
近期活跃度降低,过去20天平均换手率-0.29

Labcorp Holdings Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Labcorp Holdings Inc简介

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
公司代码LH
公司Labcorp Holdings Inc
CEOSchechter (Adam H)
网址https://www.labcorp.com/

常见问题

Labcorp Holdings Inc(LH)的当前股价是多少?

Labcorp Holdings Inc(LH)的当前股价是 264.180。

Labcorp Holdings Inc的股票代码是什么?

Labcorp Holdings Inc的股票代码是LH。

Labcorp Holdings Inc股票的52周最高点是多少?

Labcorp Holdings Inc股票的52周最高点是293.720。

Labcorp Holdings Inc股票的52周最低点是多少?

Labcorp Holdings Inc股票的52周最低点是209.375。

Labcorp Holdings Inc的市值是多少?

Labcorp Holdings Inc的市值是21.93B。

Labcorp Holdings Inc的净利润是多少?

Labcorp Holdings Inc的净利润为746.00M。

现在Labcorp Holdings Inc(LH)的股票是买入、持有还是卖出?

根据分析师评级,Labcorp Holdings Inc(LH)的总体评级为买入,目标价格为299.753。

Labcorp Holdings Inc(LH)股票的每股收益(EPS TTM)是多少

Labcorp Holdings Inc(LH)股票的每股收益(EPS TTM)是10.252。
KeyAI